Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment of Schizophrenia”

1,316 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,316 results

Not applicableStudy completedNCT00018642
What this trial is testing

Quetiapine vs Haloperidol Decanoate for the Long Term Treatment of Schizophrenia and Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
US Department of Veterans Affairs
Testing effectiveness (Phase 2)Study completedNCT03751280
What this trial is testing

Study of Efficacy of PEAR-004 in Schizophrenia

Who this might be right for
Schizophrenia
Novartis Pharmaceuticals 112
Post-approval studies (Phase 4)Study completedNCT00191555
What this trial is testing

Efficacy Study of Switching Stabilized Schizophrenic Patients From Conventional to Atypical Antipsychotic Treatment

Who this might be right for
Schizophrenia
Eli Lilly and Company 360
Not applicableStudy completedNCT02531243
What this trial is testing

Computer-Aided Learning for Managing Stress

Who this might be right for
Psychosis
Beth Israel Deaconess Medical Center 25
Not applicableStudy completedNCT04902066
What this trial is testing

Face Your Fears: Cognitive Behavioural Virtual Reality Therapy for "Paranoia".

Who this might be right for
Paranoid SchizophreniaSchizophrenia and Related DisordersSchizophrenia Prodromal+8 more
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital 259
Not applicableStudy completedNCT02600741
What this trial is testing

Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)

Who this might be right for
Schizophrenia
Janssen Scientific Affairs, LLC 296
Large-scale testing (Phase 3)Study completedNCT03503318
What this trial is testing

Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia

Who this might be right for
Schizophrenia
Teva Branded Pharmaceutical Products R&D, Inc. 544
Not applicableStudy completedNCT01391390
What this trial is testing

Melatonin Treatment for Tardive Dyskinesia in Schizophrenia

Who this might be right for
Tardive Dyskinesia
Beijing HuiLongGuan Hospital 120
Not applicableStudy completedNCT00996242
What this trial is testing

An Exploratory Open Label Study of Adjunctive L-lysine Treatment in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Göteborg University 10
Large-scale testing (Phase 3)Study completedNCT00366171
What this trial is testing

Open Label Extension Study of Bifeprunox

Who this might be right for
Schizophrenia
Wyeth is now a wholly owned subsidiary of Pfizer 120
Testing effectiveness (Phase 2)Study completedNCT01548612
What this trial is testing

Add-on Sodium Nitroprusside to Treatment as Usual in Schizophrenia

Who this might be right for
Schizophrenia
University of Sao Paulo 20
Large-scale testing (Phase 3)Study completedNCT02013609
What this trial is testing

Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work Environment

Who this might be right for
MDD
Otsuka Pharmaceutical Development & Commercialization, Inc. 48
Post-approval studies (Phase 4)Study completedNCT00239109
What this trial is testing

Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia.

Who this might be right for
Schizophrenia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 112
Post-approval studies (Phase 4)Not Yet RecruitingNCT06546475
What this trial is testing

A Pilot Trial of Tapering Antipsychotics for Patients in Remitted Psychosis Co-administering With N-Acetylcysteine

Who this might be right for
Psychosis
National Taiwan University Hospital 20
Large-scale testing (Phase 3)Study completedNCT00237809
What this trial is testing

D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Yale University 104
Large-scale testing (Phase 3)WithdrawnNCT00000372
What this trial is testing

Glycine and D-Cycloserine in Schizophrenia

Who this might be right for
Schizophrenia
Massachusetts General Hospital
Large-scale testing (Phase 3)Study completedNCT00401973
What this trial is testing

Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine

Who this might be right for
SchizophreniaSchizoaffective Disorders
Eli Lilly and Company 199
Large-scale testing (Phase 3)Study completedNCT02717195
What this trial is testing

Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia

Who this might be right for
Schizophrenia
H. Lundbeck A/S 1,098
Not applicableStudy completedNCT02976077
What this trial is testing

RC2S+: Remediation of Social Cognitive Impairments

Who this might be right for
Schizophrenia
Hôpital le Vinatier 50
Testing effectiveness (Phase 2)Study completedNCT00594256
What this trial is testing

Sodium Oxybate in Schizophrenia With Insomnia

Who this might be right for
SchizophreniaInsomnia Related to Schizophrenia (307.42)
Nathan Kline Institute for Psychiatric Research 8
Next Page